Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Er Therapeutics Inc. Stock Analysis PNGM
United States N/A Nano Cap Pengram Corp. is an advanced gold exploration company. The company is headquartered in Bellingham, Washington and currently employs 0 full-time employees. The company went IPO on 2007-08-10. The firm has not realized any revenues from its planned operations. The firm is engaged in acquiring exploration and development of natural resource properties. The firm has not commenced business operations. The firm has interests in Clisbako claims and Eureka claims. The firm has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The firm also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.
Read More Er Therapeutics Inc (PNGM) Chart
Key Statistics of Er Therapeutics Inc (PNGM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
10.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
10.00KAvg. Volume
10.00KDividend Yield
-Financial Metrics & Statements of Er Therapeutics Inc (PNGM)
FAQ's for Er Therapeutics Inc (PNGM)
- According to Musaffa’s Shariah screening methodology, Er Therapeutics Inc (PNGM) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Er Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Er Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Er Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Er Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Er Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.